UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2028
United States Clinical Trials Support Services Market by Phase (Phase I, Phase II, Phase III, Phase IV) Market by Sponsor (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Other Sponsors) Market by Service (Clinical Trial Site Management, Administrative Services, Patient Recruitment Management, Regulatory Services, Data Management, Other Services)
The United States clinical trials support services market is anticipated to reach $12740.97 million in revenue by 2028, surging with a 7.32% CAGR over the forecast period, 2022-2028.
The clinical trial demands are expanding in the United States because of the rising frequency of chronic disorders and the requirements for clinical trials in developing nations. The market of the United States clinical trials support services is supported by the demand to undertake clinical studies for contract research organizations and the rising number of biologics in the market.
To know more about this report, request a free sample copy
In addition, various pharmaceutical and biotechnology companies are currently conducting clinical trials for infectious and chronic disorders such as HIV, cancer, etc., which is expected to help expand the United States clinical trials support services market. Also, favorable government assistance for clinical trials in the country is expected to stimulate market growth.
Furthermore, the shift towards personalized medicine, growing disease variation, and increasing R&D investments are favoring the market growth in the United States. Besides, there has been a rapid surge in the number of diseases. This results in an increased R&D expenditure by the pharmaceutical companies to launch new therapeutics. Furthermore, due to outsourcing services, the costs involved in clinical trials are significantly low, strengthening the clinical trials support services market in the United States.
The United States clinical trials support services market is segmented into sponsor, phase, and service. Market by service covers regulatory services, administrative services, patient recruitment management, data management, clinical trial site management, and other services.
Patient recruitment is an integral part of the clinical trial process. Finding healthy patients and convincing them for the clinical trial process is challenging. Also, insufficient or untimely patient recruitment into clinical trials has significant consequences. Further, the trial timeline could be extended, increasing the clinical trial’s cost. However, long trials could also not deliver timely treatment to the population.
Several challenges are faced while recruiting the patients for the clinical trial process, such as protocol or trial-specific recruitment issues, feasibility issues, patient-related recruitment issues, etc. Hence, globally leading companies offer various solutions for patient recruitment management, such as direct-to-patient recruitment, which provides a recruitment strategy that eliminates issues that add to the cost, time, and complications of the current recruiting system.
IRB is known as the Institutional Review Board, which is an integral part of regulatory services. An IRB is an ethics-based review committee that ensures that human research subjects’ rights and the rights of the patients who will be benefitted from the research are protected. The IRB operates under United States federal regulations, state laws, and institutional policies. It can require modification and can approve or disapprove of research.
Furthermore, there are certain responsibilities of IRB, like concluding research subjects provided with informed consent forms that include all required information about the extent and nature of the activities involved and confirm if the forms are signed post-reviewing by the trial subjects. The IRB also protects the interests of human subjects to ensure an appropriate balance of risks and benefits of the trials.
Top players operating in the United States clinical trials support services market entail Charles River Laboratories Inc, Parexel, Syneos Health, IQVIA, etc.
Charles River Laboratories Inc is a contract research organization (CRO) that offers products and services like discovery services, avian vaccine services, QC Microbial solutions, laboratory sciences, research models and services. It also provides the research phase, molecule type, industry therapeutic, and area solutions. It operates in Latin America, North America, Asia-Pacific, and Europe. Charles River Laboratories was founded in 1947 and is currently headquartered in Massachusetts, United States.
Mouse Genotyping services from Charles River Laboratories are fully customized to suit projects, including testing multiple tissues and custom assay development options. It can run multiple allele-specific assays, including qPCR, PCR, and single SNP assays.
Report Synopsis
Report Scope | Details |
Market Forecast Years | 2022-2028 |
Base Year | 2021 |
Market Historical Years | 2018-2021 |
Forecast Units | Revenue ($ Million) |
Segments Analyzed | Phase, Sponsor, and Service |
Country Analyzed | United States |
Companies Analyzed | Charles River Laboratories Inc, Clinipace, IQVIA, Labcorp Drug Development, Medpace, Parexel, Syneos Health |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- COUNTRY SNAPSHOT
- COUNTRY ANALYSIS
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY ANALYTICS
- IMPACT OF COVID -19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
- PESTLE ANALYSIS – UNITED STATES
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VALUE CHAIN ANALYSIS
- SOLUTION PROVIDERS
- SERVICE PROVIDERS
- END-USER INDUSTRIES
- KEY BUYING CRITERIA
- PERFORMANCE
- EASE OF USE
- SECURITY
- COST EFFECTIVENESS
- REGULATORY FRAMEWORK
- MARKET BY PHASE
- PHASE I
- PHASE II
- PHASE III
- PHASE IV
- MARKET BY SPONSOR
- PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- MEDICAL DEVICE COMPANIES
- OTHER SPONSORS
- MARKET BY SERVICE
- CLINICAL TRIAL SITE MANAGEMENT
- ADMINISTRATIVE SERVICES
- PATIENT RECRUITMENT MANAGEMENT
- PATIENT RECRUITMENT & REGISTRY SERVICES
- PATIENT RETENTION
- OTHER PATIENT RECRUITMENT MANAGEMENT
- REGULATORY SERVICES
- DATA MANAGEMENT
- OTHER SERVICES
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- CHARLES RIVER LABORATORIES INC
- CLINIPACE
- IQVIA
- LABCORP DRUG DEVELOPMENT
- MEDPACE
- PAREXEL
- SYNEOS HEALTH
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 10: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 12: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 14: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 16: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 7: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 8: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 9: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 10: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 11: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 12: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 13: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 14: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 15: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 16: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 17: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 18: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 19: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 20: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 21: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2028 (IN $ MILLION)
FIGURE 22: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 23: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 24: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 25: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
- MARKET BY PHASE
- PHASE I
- PHASE II
- PHASE III
- PHASE IV
- MARKET BY SPONSOR
- PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- MEDICAL DEVICE COMPANIES
- OTHER SPONSORS
- MARKET BY SERVICE
- CLINICAL TRIAL SITE MANAGEMENT
- ADMINISTRATIVE SERVICES
- PATIENT RECRUITMENT MANAGEMENT
- PATIENT RECRUITMENT & REGISTRY SERVICES
- PATIENT RETENTION
- OTHER PATIENT RECRUITMENT MANAGEMENT
- REGULATORY SERVICES
- DATA MANAGEMENT
- OTHER SERVICES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.